The sheer number and diverse mechanisms of these viral protein-mediated interferences underscore the challenge SARS-CoV-2 poses to an effective host innate immune response, directly contributing to delayed or dampened IFN production and, consequently, severe COVID-19 pathology. The gene discussed is IFNA1; the disease is COVID-19.